The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2008, 180, 4246-4255
Copyright © 2008 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Louis, N. A.
Right arrow Articles by Colgan, S. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Louis, N. A.
Right arrow Articles by Colgan, S. P.

Control of IFN-{alpha}A by CD73: Implications for Mucosal Inflammation1

Nancy A. Louis2,3,*,{dagger},{ddagger}, Andreas M. Robinson3,{dagger}, Christopher F. MacManus§, Jörn Karhausen, Melanie Scully{dagger},§ and Sean P. Colgan{dagger},§

* Neonatology Division and {dagger} Center for Experimental Therapeutics and Reperfusion Injury, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115; {ddagger} Division of Neonatal-Perinatal Medicine, Emory University School of Medicine, Atlanta, GA 30322; § Mucosal Inflammation Program, Division of Gastroenterology, University of Colorado Health Sciences Center, Denver, CO 80262; and Abteilung Anästhesiologie und Transfusionsmedizin, Universitätsklinik Tübingen, Tübingen, Germany

Inflammatory diseases influence tissue metabolism, altering regulation of extracellular adenine nucleotides, with a resultant protective influence of adenosine. Ecto-5'-nucleotidase (CD73) is a central surface enzyme generating extracellular adenosine. Thus, we hypothesized that CD73 is protective in mucosal inflammation as modeled by trinitrobenzene sulfonate (TNBS) colitis. Initial studies revealed a >3-fold induction of CD73 mRNA levels after TNBS colitis. Additionally, the severity of colitis was increased, as determined by weight loss and colonic shortening, in cd73–/– mice relative to cd73+/+ controls. Likewise, enteral administration of the selective CD73 inhibitor {alpha},β-methylene ADP to cd73+/+ mice resulted in a similar increase in severity of TNBS colitis. Gene array profiling of cytokine mRNA expression, verified by real-time PCR, revealed a >90% down-regulation of IFN-{alpha}A in cd73–/– mice and {alpha},β-methylene ADP-treated cd73+/+ mice, compared with cd73+/+ mice. Exogenous administration of recombinant IFN-{alpha}A partially protected TNBS-treated cd73–/– mice. Cytokine profiling revealed similar increases in both IFN-{gamma} and TNF-{alpha} mRNA in colitic animals, independent of genotype. However, IL-10 mRNA increased in wild-type mice on day 3 after TNBS administration, whereas cd73–/– mice mounted no IL-10 response. This IL-10 response was restored in the cd73–/– mice by exogenous IFN-{alpha}A. Further cytokine profiling revealed that this IL-10 induction is preceded by a transient IFN-{alpha}A induction on day 2 after TNBS exposure. Together, these studies indicate a critical regulatory role for CD73-modulated IFN{alpha}A in the acute inflammatory phase of TNBS colitis, thereby implicating IFN-{alpha}A as a protective element of adenosine signaling during mucosal inflammation.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by National Institutes of Health Grants DK50189, DE016191, HL60569, and DK62007 and by a grant from the Crohn’s and Colitis Foundation of America. S.P.C. holds the Kern Family Professorship of Medicine at the University of Colorado Health Sciences Center.

2 Address correspondence and reprint requests to Dr. Nancy A. Louis, Emory University School of Medicine, 2015 Uppergate Drive Northeast, Atlanta, GA 30322. E-mail address: nancy_louis{at}oz.ped.emory.edu

3 N.A.L. and A.M.R. contributed equally to this work.

4 Abbreviations used in this paper: TNBS, trinitrobenzene sulfonate; CD73, ecto-5'-nucleotidase; Ado, adenosine; APCP, {alpha},β-methylene ADP; PMN, polymorphonuclear cell or neutrophil; A2AR, adenosine A2A receptor; A2BR, adenosine A2B receptor; pDC, plasmacytoid dendritic cells.




This article has been cited by other articles:


Home page
FASEB J.Home page
S. Keely, L. E. Glover, C. F. MacManus, E. L. Campbell, M. M. Scully, G. T. Furuta, and S. P. Colgan
Selective induction of integrin {beta}1 by hypoxia-inducible factor: implications for wound healing
FASEB J, May 1, 2009; 23(5): 1338 - 1346.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J.-S. Frick, C. F. MacManus, M. Scully, L. E. Glover, H. K. Eltzschig, and S. P. Colgan
Contribution of Adenosine A2B Receptors to Inflammatory Parameters of Experimental Colitis
J. Immunol., April 15, 2009; 182(8): 4957 - 4964.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2008 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2008 by The American Association of Immunologists, Inc. All rights reserved.